Schedule 13G ownership disclosure
CLOVIS ONCOLOGY INC
Security class unavailable · CUSIP: 189464100
Event date: 2019-11-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,803,753
- Percent of class
- 6.4900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-19-004473
- Form type
- SC 13G
- Filer
- Clovis Oncology, Inc.
- CIK
- CIK 1466301
- Filed
- Dec 02, 2019
- Reporting period
- Nov 20, 2019
- Description
- Schedule 13G beneficial ownership